ERBB2 and breast cancer: The plasmids were transfected into two breast cancer cell models, namely, the human ER-α+ breast adenocarcinoma MCF-7 cell line and the triple-negative (ER-α−, HER2−, PR−) breast adenocarcinoma MDA-MB-231 cell line.